Trademark Overview
On Wednesday, November 26, 2025, a trademark application was filed for ARASTATIN with the United States Patent and Trademark Office. The USPTO has given the ARASTATIN trademark a serial number of 79448312. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Thursday, April 23, 2026. This trademark is owned by Araris Biotech AG. The ARASTATIN trademark is filed in the Chemical Products, Pharmaceutical Products, Advertising, Business and Retail Services, and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical products, medical preparations; pharmaceuticals and medical preparations in the field of cancer therapy; biopharmaceuticals and medical preparations in the field of active antibody conjugates; chemical, biological, molecular genetic and biochemical and biopharmaceutical products for medical, pharmaceutical use, namely peptides, peptide derivatives, proteins, antibodies, active antibody conjugates, antibody fragments, antibody derivatives, nucleic acids, DNA, vectors; pharmaceutical products and substances for the treatment of diseases and preparations for medical treatments.
Chemical, biochemical, biological and molecular genetic products intended for laboratory analysis, industry and science; bioactive reagents and compounds; peptides, peptide derivatives, proteins, glycans, nucleotides, lipids, antibodies, antibody-active principle conjugates, antibody fragments, antibody derivatives, nucleic acids, DNA, vectors; chemical, biochemical, biological, biotechnological and molecular genetic preparations for industrial and scientific use; chemical, biological, biotechnological and molecular genetic preparations, namely polypeptides and proteins for reagent development or production for industrial and scientific applications; biological preparations, namely polypeptides, peptide derivatives or proteins for laboratories and analysis for industrial and scientific applications; chemical and biochemical substances for use in the manufacture of pharmaceuticals.
Scientific and technological services as well as research work and design services relating thereto, namely, services provided by scientists dedicated to the chemical and technological study of biological molecules; scientific, medical, biological, molecular genetic, chemical, pharmaceutical and technological research, in the field of biochemistry or pharmacy; services of a biochemical or pharmaceutical laboratory; industrial analysis and research services; development and experimentation of medicines; conducting preclinical and clinical trials; laboratory services for the benefit of third parties; scientific advisory services in the biochemical, biological and molecular genetic fields; scientific advice for the pharmaceutical industry sector; analysis services for medical and pharmaceutical research services in connection with the treatment of individuals, included in class 42; provision of scientific research information and results.
Providing information with respect to business contacts for research projects.
